| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 56,391 | 76,972 | ||
| Short-term marketable securities | 0 | 0 | ||
| Accounts receivable | 168 | 266 | ||
| Prepaid expenses and other current assets | 3,429 | 2,903 | ||
| Total current assets | 59,988 | 80,141 | ||
| Property and equipment, net | 163 | 1,037 | ||
| Operating lease right-of-use assets | 2,035 | 2,895 | ||
| Other assets, noncurrent | 500 | 500 | ||
| Total assets | 62,686 | 84,573 | ||
| Accounts payable | 2,393 | 2,923 | ||
| Accrued expenses | 14,813 | 15,184 | ||
| Deferred revenue | 23,770 | 20,183 | ||
| Operating lease liabilities | 2,293 | 3,270 | ||
| Short-term debt, net | 0 | 17,351 | ||
| Other current liabilities | 0 | 427 | ||
| Total current liabilities | 43,269 | 59,338 | ||
| Operating lease liabilities, noncurrent | 0 | 0 | ||
| Long-term debt, net | 0 | 0 | ||
| Deferred revenue, noncurrent | 78,954 | 78,381 | ||
| Other liabilities, noncurrent | 0 | 0 | ||
| Total liabilities | 122,223 | 137,719 | ||
| Additional paid-in capital | 891,980 | 890,826 | ||
| Accumulated other comprehensive income | 0 | 0 | ||
| Accumulated deficit | -951,517 | -943,972 | ||
| Total stockholders deficit | -59,537 | -53,146 | ||
| Total liabilities and stockholders deficit | 62,686 | 84,573 | ||
Mersana Therapeutics, Inc. (MRSN)
Mersana Therapeutics, Inc. (MRSN)